• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三级医疗中心新诊断的儿童免疫性血小板减少性紫癜的临床特征及预后

Clinical features and outcome in paediatric newly diagnosed immune thrombocytopenic purpura in a tertiary care centre.

作者信息

Zafar Huma, Anwar Saadia, Faizan Mahwish, Riaz Shazia

机构信息

Huma Zafar, FCPS. Department of Paediatric Haematology, Oncology and Bone Marrow Transplant, The Children's Hospital and the Institute of Child Health, Lahore, Pakistan.

Saadia Anwar, FCPS. Department of Paediatric Haematology, Oncology and Bone Marrow Transplant, The Children's Hospital and the Institute of Child Health, Lahore, Pakistan.

出版信息

Pak J Med Sci. 2018 Sep-Oct;34(5):1195-1199. doi: 10.12669/pjms.345.15687.

DOI:10.12669/pjms.345.15687
PMID:30344575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6191794/
Abstract

OBJECTIVE

The study aimed to demonstrate the pattern of clinical presentations and outcome of acute Immune Thrombocytopenia (ITP) in our Centre.

METHODS

A descriptive, observational study was conducted by collecting and analysing the data of 103 patients of acute ITP, ageing between 1-14 years, at The Children's Hospital, Lahore from January 2016 to December 2016. We collected the data regarding age, sex, clinical presentations, history of preceding viral infections, vaccination history, laboratory values, different treatment options used, and response to the treatment concerning complete response, partial response and poor responders. Statistical analysis performed by using IBM SPSS statistics version 20.

RESULTS

We retrospectively, reviewed total 103 patients cases. The median age, at the time of presentation, was 5±3.4 years while mean age was 4.5±2.9 years. The male to female ratio was 1.28:1. Mean platelet count on presentation was 7 x 10/L (range: 0-24). Twenty three (22.3%), patients had the history of preceding illness. Bruises, petechiae, epistaxis and hematemesis remained the common presentations. Six (5.8%) patients showed spontaneous recovery while 97 (94%) patients received treatment for ITP. Overall, 71 (68.9%) showed a response after treatment. Sixty-two patients (59.22%) showed loss of response and received treatment again. Among these patients, thirty-four patients (33%) developed chronic disease.

CONCLUSION

Majority of patients presenting to our tertiary care centre had severe acute ITP on presentation. After management and follow-up, almost 1/3 of the patients develop chronic disease hence the incidence of developing chronic disease remained high as compared to the other centers.

摘要

目的

本研究旨在展示我院中心急性免疫性血小板减少症(ITP)的临床表现模式及治疗结果。

方法

2016年1月至2016年12月期间,在拉合尔儿童医院对103例年龄在1至14岁之间的急性ITP患者的数据进行收集和分析,开展了一项描述性观察性研究。我们收集了有关年龄、性别、临床表现、既往病毒感染史、疫苗接种史、实验室检查值、所采用的不同治疗方案以及治疗反应(完全缓解、部分缓解和无反应者)的数据。使用IBM SPSS statistics 20版本进行统计分析。

结果

我们回顾性地分析了103例患者的病例。就诊时的中位年龄为5±3.4岁,平均年龄为4.5±2.9岁。男女比例为1.28:1。就诊时的平均血小板计数为7×10/L(范围:0 - 24)。23例(22.3%)患者有前驱疾病史。瘀斑、瘀点、鼻出血和呕血仍是常见表现。6例(5.8%)患者自发恢复,97例(94%)患者接受了ITP治疗。总体而言,71例(68.9%)患者治疗后有反应。62例患者(59.22%)反应消失并再次接受治疗。在这些患者中,34例(33%)发展为慢性病。

结论

在我们的三级护理中心就诊的大多数患者初诊时患有严重急性ITP。经过治疗和随访,近三分之一的患者发展为慢性病,因此与其他中心相比,发展为慢性病的发生率仍然很高。

相似文献

1
Clinical features and outcome in paediatric newly diagnosed immune thrombocytopenic purpura in a tertiary care centre.三级医疗中心新诊断的儿童免疫性血小板减少性紫癜的临床特征及预后
Pak J Med Sci. 2018 Sep-Oct;34(5):1195-1199. doi: 10.12669/pjms.345.15687.
2
Idiopathic thrombocytopenic purpura in children: a 10 years experience at tertiary care hospital.儿童特发性血小板减少性紫癜:一家三级护理医院的10年经验
J Pak Med Assoc. 2014 Dec;64(12):1358-62.
3
Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity.回顾性评估儿童免疫性血小板减少性紫癜及导致其慢性化的相关因素。
Pediatr Neonatol. 2019 Aug;60(4):411-416. doi: 10.1016/j.pedneo.2018.10.002. Epub 2018 Nov 3.
4
Clinical Characteristics and Outcomes of Pediatric Patients With Immune Thrombocytopenic Purpura in King Abdulaziz Medical City and King Abdullah Specialist Children's Hospital: A 10-Year Study.阿卜杜勒阿齐兹国王医疗城和阿卜杜拉国王专科医院儿童免疫性血小板减少性紫癜患者的临床特征及转归:一项10年研究
Cureus. 2020 Nov 6;12(11):e11366. doi: 10.7759/cureus.11366.
5
Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama.特发性血小板减少性紫癜:阿拉巴马儿童医院的一项为期10年的自然史研究。
Clin Pediatr (Phila). 2004 Oct;43(8):691-702. doi: 10.1177/000992280404300802.
6
Importance of immature platelet fraction as predictor of immune thrombocytopenic purpura.未成熟血小板分数作为免疫性血小板减少性紫癜预测指标的重要性。
Pak J Med Sci. 2016 May-Jun;32(3):575-9. doi: 10.12669/pjms.323.9456.
7
Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura.对208例慢性特发性血小板减少性紫癜成人患者的长期观察。
Am J Med. 1995 May;98(5):436-42. doi: 10.1016/s0002-9343(99)80342-8.
8
[Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000].[1998 - 2000年丹麦儿童特发性血小板减少性紫癜的流行病学、疾病表现及病程]
Ugeskr Laeger. 2008 May 26;170(22):1922-6.
9
Clinical feature and management of immune thrombocytopenic purpura in a tertiary hospital in Northwest Nigeria.尼日利亚西北部一家三级医院免疫性血小板减少性紫癜的临床特征与管理
Niger Med J. 2017 Mar-Apr;58(2):68-71. doi: 10.4103/0300-1652.219343.
10
[Idiopathic thrombocytopenic purpura in children].[儿童特发性血小板减少性紫癜]
Med Pregl. 1998 Mar-Apr;51(3-4):127-34.

本文引用的文献

1
Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants.新诊断免疫性血小板减少症患儿缓解的预测因素:来自洲际合作免疫性血小板减少症研究组登记处II参与者的数据。
Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26736. Epub 2017 Aug 9.
2
Immune Thrombocytopenic Purpura in Children of Eastern Henan Province, China.中国河南省东部儿童免疫性血小板减少性紫癜
Indian Pediatr. 2016 Nov 15;53(11):1024-1025.
3
Importance of immature platelet fraction as predictor of immune thrombocytopenic purpura.未成熟血小板分数作为免疫性血小板减少性紫癜预测指标的重要性。
Pak J Med Sci. 2016 May-Jun;32(3):575-9. doi: 10.12669/pjms.323.9456.
4
Clinical Features and Treatment Outcomes of Primary Immune Thrombocytopenic Purpura in Hospitalized Children Under 2-Years Old.2岁以下住院儿童原发性免疫性血小板减少症的临床特征及治疗结果
Iran J Ped Hematol Oncol. 2016;6(1):24-31. Epub 2016 Mar 15.
5
Idiopathic thrombocytopenic purpura in children: a 10 years experience at tertiary care hospital.儿童特发性血小板减少性紫癜:一家三级护理医院的10年经验
J Pak Med Assoc. 2014 Dec;64(12):1358-62.
6
Clinical and laboratory predictors of chronic immune thrombocytopenia in children: a systematic review and meta-analysis.儿童慢性免疫性血小板减少症的临床和实验室预测因素:系统评价和荟萃分析。
Blood. 2014 Nov 20;124(22):3295-307. doi: 10.1182/blood-2014-04-570127. Epub 2014 Oct 10.
7
Childhood Immune Thrombocytopenia: Long-term Follow-up Data Evaluated by the Criteria of the International Working Group on Immune Thrombocytopenic Purpura.儿童免疫性血小板减少症:采用国际免疫性血小板减少性紫癜工作组标准评估的长期随访数据。
Turk J Haematol. 2014 Mar;31(1):32-9. doi: 10.4274/Tjh.2012.0049. Epub 2014 Mar 5.
8
Clinical presentations in immune thrombocytopenic purpura.免疫性血小板减少性紫癜的临床表现。
J Ayub Med Coll Abbottabad. 2012 Apr-Jun;24(2):39-40.
9
Vaccine administration and the development of immune thrombocytopenic purpura in children.疫苗接种与儿童免疫性血小板减少性紫癜的发病。
Hum Vaccin Immunother. 2013 May;9(5):1158-62. doi: 10.4161/hv.23601. Epub 2013 Jan 16.
10
The risk of immune thrombocytopenic purpura after vaccination in children and adolescents.儿童和青少年接种疫苗后的免疫性血小板减少性紫癜风险。
Pediatrics. 2012 Feb;129(2):248-55. doi: 10.1542/peds.2011-1111. Epub 2012 Jan 9.